NovoSynth Pharmaceuticals LLC

Company Description

NovoSynth Pharmaceuticals is a knowledge based and a customer focused company, supporting clients across the value chain: R&D, Manufacturing, Sales & Marketing. We enable the faster / more effective advancement of our clients' commercialization efforts: (i) Open doors to collaborations across the value chain, globally (ii) Supporting CMC and Supply-Chain management activities (iii) Facilitate the introduction of products and services to new markets. We have presence in US, Europe & China and direct access to pharmaceutical suppliers and manufacturers. Our network of chemical suppliers and service providers can work together to meet our customers' speed to market objectives and deliver quality, security of supply and cost competitiveness

Company Information

• Country/Region: United States
• Address: 13 Hempstead DrZ Suite 700, Newark, DE, USA
• Website: www.novosynthpharmaceuticals.com
• Business Type: Business Services
• Main Products: Insulin,
• Year Established: 2010
• Number Of Employess: 1-5
• Main Markets: Americas,Asia,East Europe,Middle East
• Production Capacity: 1
• R&D Capacity: Less than 5 people
• Quality Control: In House
• No. of QC Staff: Less than 5 people
• Registered Capital: Less than 1 Million USD
• Total Annual Sales Volume: Less than 1 Million USD

Contact info

• Contact Person: Ms.Olena Angiulli
• Department: CEO
• Telephone:
• Zip/Post Code: 19702